A study conducted in Israel and published in the journal Jama Internal Medicine found that the booster dose of the Pfizer and BioNTech vaccine reduces the risk of testing positive for COVID-19 by 80% or more.
The team followed more than 300,000 people aged 40 and over who received this vaccine.